Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

31.87
Delayed Data
As of May 22
 -0.61 / -1.88%
Today’s Change
20.79
Today|||52-Week Range
37.32
-4.87%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close32.48
Today’s open32.52
Day’s range31.83 - 32.73
Volume178,732
Average volume (3 months)197,889
Market cap$619.8M
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratioNM
Price/Sales5.80
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...-0.12-2.81%
BYSIBeyondspring Inc+1.28+4.58%
VSARVersartis Inc+0.40+2.51%
PRTKParatek Pharmaceutic...-0.20-0.93%
Data as of 3:59pm ET, 05/22/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Jay R. Luly
CFO, Senior VP-Finance &
Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts